Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05625373 · ClinicalTrials.gov registry record · Phase 2
The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
A Phase 2 study of Postoperative Complications, sponsored by Women and Infants Hospital of Rhode Island.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05625373: Recruiting Phase 2 study of Postoperative Complications, sponsored by Women and Infants Hospital of Rhode Island.
NCT05625373 is a Phase 2 study of Postoperative Complications that is actively recruiting participants, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 30 participants, below the 560-participant average among 20 other Postoperative Complications trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05625373, a Phase 2 study of Postoperative Complications, is actively recruiting participants, sponsored by Women and Infants Hospital of Rhode Island.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will be a pilot randomized control trial with a 1:1 patient randomization of vancomycin powder placement at the time of surgery (compared to no vancomycin placement) with the goal of reducing postoperative complications in patients undergoing an inguinal lymph node dissection for vulvar cancer. The primary objective is to measure the composite rate of postoperative complications within 30 days of inguinal lymph node dissection in patients with vulvar cancer.
Primary Outcome
Rate of composite postoperative complications including inguinal wound infection (superficial and deep surgical site infection), inguinal incision separation, and hospital readmission within 30 days
Conditions Studied
Interventions
- DRUG Vancomycin
Study Locations (1)
Rhode Island
- Women and Infants Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-10-25 |
| Est. Completion | 2024-08-30 |
| Phase | Phase 2 |
What NCT05625373 shows while recruiting
NCT05625373 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 560-participant average among 20 other Postoperative Complications trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Postoperative Complications appearing as the primary indexed condition, and to 1 intervention - of which Vancomycin is the first listed.
NCT05625373 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05625373 about?
NCT05625373 is a clinical study titled "The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection". The study will be a pilot randomized control trial with a 1:1 patient randomization of vancomycin powder placement at the time of surgery (compared to no vancomycin placement) with the goal of reducing postoperative complications in patients undergoing an inguinal lymph node dissection for vulvar ca...
What is the current status of trial NCT05625373?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2022-10-25. Estimated completion is 2024-08-30.
What conditions does trial NCT05625373 study?
This clinical trial studies the following conditions: Postoperative Complications.
What interventions are being tested in trial NCT05625373?
The interventions under investigation include: Vancomycin (DRUG).
Who is sponsoring clinical trial NCT05625373?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05625373 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05625373's enrollment target sits among peer trials
30 19th of 20 higher than 1 of 20 other Postoperative Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition to Support Postoperative Recovery
RECRUITING · NA
-
Minimally Invasive Esophagectomy Pain Control Trial
RECRUITING · Phase 1
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
-
Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures
RECRUITING
-
Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
RECRUITING
-
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI